Torrent Pharmaceuticals Limited Share Price

Equities

TORNTPHARM

INE685A01028

Pharmaceuticals

Market Closed - Bombay S.E. 03:30:50 26/04/2024 pm IST 5-day change 1st Jan Change
2,690 INR -0.07% Intraday chart for Torrent Pharmaceuticals Limited +6.05% +16.72%
Sales 2024 * 108B 1.3B Sales 2025 * 122B 1.46B Capitalization 911B 10.92B
Net income 2024 * 16.43B 197M Net income 2025 * 20.55B 247M EV / Sales 2024 * 8.76 x
Net Debt 2024 * 37.16B 446M Net Debt 2025 * 25.26B 303M EV / Sales 2025 * 7.67 x
P/E ratio 2024 *
56.1 x
P/E ratio 2025 *
44.3 x
Employees 13,247
Yield 2024 *
0.8%
Yield 2025 *
0.9%
Free-Float 28.64%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.07%
1 week+6.05%
Current month+3.43%
1 month+4.93%
3 months+8.74%
6 months+39.96%
Current year+16.72%
More quotes
1 week
2 537.15
Extreme 2537.15
2 730.40
1 month
2 508.65
Extreme 2508.65
2 730.40
Current year
2 270.15
Extreme 2270.15
2 745.55
1 year
1 599.00
Extreme 1599
2 745.55
3 years
1 238.83
Extreme 1238.825
2 745.55
5 years
726.50
Extreme 726.5
2 745.55
10 years
280.00
Extreme 280
2 745.55
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
Compliance Officer - 01/22/01
Chief Operating Officer 47 01/19/01
Members of the board TitleAgeSince
Director/Board Member 70 23/82/23
Chairman 60 01/86/01
Director/Board Member 57 07/19/07
More insiders
Date Price Change Volume
26/24/26 2,690 -0.07% 4,270
25/24/25 2,692 +0.28% 1,149
24/24/24 2,685 +1.85% 4,480
23/24/23 2,636 +1.76% 1,466
22/24/22 2,591 +2.12% 4,372

Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST

More quotes
Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is focused on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. Its pediatric product brands include Tedibar, Atogla, Spoo and B4 Nappi. Its acne/facecare products brands include Clinmiskin, ACNEMOIST, TRACNILO and fash. The Company's hair/scalp care products brands include Proanagen, Perlice, Permite and NOSKURF. Its manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim. The Company's primary channel of distribution is through the wholesale drug distributors, stockiest and retail pharmacies.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
2,690 INR
Average target price
2,729 INR
Spread / Average Target
+1.43%
Consensus
  1. Stock Market
  2. Equities
  3. TORNTPHARM Stock